Award
National Institute of Allergy and Infectious Diseases 4R44AI170285-02
Process development for manufacturing eCD4-Ig
Recipient
EMMUNE, INC
Award Amount
$999,997.00
Ceiling
$999,997.00
Awarded
September 23, 2025
Identifier
4R44AI170285-02
NIH awarded a grant to EMMUNE, INC for process development and manufacturing of eCD4-Ig, a therapeutic for HIV, with a project duration from 2023 to 2028 and an award amount of approximately $1 million.
Description
This is a NIH SBIR/STTR grant for process development of eCD4-Ig, a therapeutic for HIV. The project involves process optimization, formulation development, and manufacturing of a GLP lot for IND-enabling studies.